Stopping statins after the onset of symptoms completely negates the drugs'protective effect in hospitalized patients with acute coronary syndromes(ACS). So concludes a new subgroup analysis of the PRISM trial.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Don't stop statins in inpatients with ACS

Newsletter